Merge Healthcare Announces Offering of $200 Million Senior Secured Notes
April 06 2010 - 11:00AM
Business Wire
Merge Healthcare Incorporated (NASDAQ: MRGE) (“Merge”) announced
today that it intends to offer $200 million aggregate principal
amount of senior secured notes due 2015, which will be used to fund
a portion of the proposed acquisition of AMICAS, Inc. (NASDAQ:
AMCS).
The notes will be senior obligations of Merge and will be
guaranteed on a senior basis by all of Merge’s domestic restricted
subsidiaries. The notes and the related guarantees will be offered
in the United States to qualified institutional buyers pursuant to
Rule 144A under the Securities Act of 1933, as amended (the
“Securities Act”), and outside the United States pursuant to
Regulation S under the Securities Act. The notes and the related
guarantees have not been registered under the Securities Act and
may not be offered or sold in the United States absent registration
or an applicable exemption from the registration requirements.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the notes or any other securities
and shall not constitute an offer, solicitation or sale in any
jurisdiction in which, or to any person to whom, such an offer,
solicitation or sale is unlawful. Any offers of the notes will be
made only by means of a private offering memorandum.
Merge Healthcare Incorporated develops solutions that
automate healthcare data and diagnostic workflow to enable a better
electronic record of the patient experience, and to enhance product
development for health IT, device and pharmaceutical companies.
Merge products, ranging from standards-based development toolkits
to sophisticated clinical applications, have been used by
healthcare providers, vendors and researchers worldwide for over 20
years. Additional information can be found at www.merge.com.
Forward Looking Statements
This press release contains certain forward-looking statements
that are subject to known and unknown risks and uncertainties that
could cause actual results to differ materially from those
expressed or implied by such statements. Such risks and
uncertainties include, but are not limited to, whether or not the
Company will offer the notes or consummate the offering, the
anticipated terms of the notes and the offering, the closing of the
combination with AMICAS, and the anticipated use of the proceeds of
the offering. Important assumptions and other important factors
that could cause actual results to differ materially from those in
the forward-looking statements are specified in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2009
including under headings such as "Forward-Looking Statements",
“Risk Factors” and "Management’s Discussion and Analysis of
Financial Condition and Results of Operations" and in other filings
and furnishings made by the Company with the SEC from time to time.
Except to the extent required by applicable federal securities
laws, the Company undertakes no obligation to release publicly any
revisions to any forward-looking statements, to report events or to
report the occurrence of unanticipated events.
Amicas (NASDAQ:AMCS)
Historical Stock Chart
From May 2024 to Jun 2024
Amicas (NASDAQ:AMCS)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Amicas (MM) (NASDAQ): 0 recent articles
More News Articles